These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

195 related items for PubMed ID: 6960081

  • 21. Econometric analysis of phase duration for blood morphology and basophil count alterations in chronic granulocytic leukaemia.
    Gola A, Smakowska E, Waszkiewicz L, Błaczkowska A, Kin-Dittmann I, Zielińska K, Czajkowska B, Pajsert E.
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1984; 111(3):271-5. PubMed ID: 6205949
    [Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23. [Adrenal function in chronic myeloid leukemia].
    Podolak-Dawidziak M, Silber-Kasprzak D.
    Acta Haematol Pol; 1984; 7(4):303-9. PubMed ID: 1069455
    [Abstract] [Full Text] [Related]

  • 24. Treatment of 100 cases of chronic myeloid leukemia with Myleran.
    Pawelski S, Topolska P, Rechowicz K, Krzyzanowska-Wozniakowska.
    Pol Med Sci Hist Bull; 1968 Jul; 11(3):101-4. PubMed ID: 5243952
    [No Abstract] [Full Text] [Related]

  • 25. The long-term results and survival in the treatment of chronic granulocytic leukaemia with Myleran.
    Chrobák L, Radochová D, Chrobáková H.
    Sb Ved Pr Lek Fak Karlovy Univerzity Hradci Kralove; 1969 Jul; 12(5):565-70. PubMed ID: 5267593
    [No Abstract] [Full Text] [Related]

  • 26. Management of chronic myeloid leukemia: a five-year survey with a comparison of oral busulfan and splenic irradiation.
    Gollerkeri MP, Shah GB.
    Cancer; 1971 Mar; 27(3):596-601. PubMed ID: 5279330
    [No Abstract] [Full Text] [Related]

  • 27. [Remarks on the course and prognostic factors in a series of chronic myeloid leukemia].
    Furno F, Neretto G, Mazza A, Giovanelli E, Agricola R, Martinetto P.
    Arch Sci Med (Torino); 1980 Mar; 137(3):499-506. PubMed ID: 6940518
    [No Abstract] [Full Text] [Related]

  • 28. [Recent concepts of chronic myeloid leukemia and its treatment].
    Bousser J, Bilski-Pasquier G, Zittoun.
    Bull Mem Soc Med Hop Paris; 1980 Mar; 117(8):665-74. PubMed ID: 5224894
    [No Abstract] [Full Text] [Related]

  • 29. Cytogenetic anomalies in a child born to a mother receiving busulfan for chronic myeloid leukaemia.
    Bhisey AN, Advani SH, Khare AG.
    Indian J Cancer; 1982 Mar; 19(5):272-6. PubMed ID: 6219940
    [No Abstract] [Full Text] [Related]

  • 30. BCG immunotherapy in chronic myelocytic leukaemia.
    Kardaszewicz E, Siejeńska L.
    J Hyg Epidemiol Microbiol Immunol; 1976 Mar; 20(1):32-5. PubMed ID: 1063221
    [No Abstract] [Full Text] [Related]

  • 31. Chronic granulocytic leukaemia. Comparison of uracil mustard and busulphan.
    Herrmann RP, Dougan L, Holt JA, Jackson JM, Matthews ML, Nelson AJ, Stenhouse NS, Woodliff HJ.
    Med J Aust; 1972 Apr 15; 1(16):789-91. PubMed ID: 4503393
    [No Abstract] [Full Text] [Related]

  • 32. Splenic irradiation in chronic myeloid leukemia.
    Hukku S, Baboo HA, Venkataratnam S, Vidyasagar MS, Patel NL.
    Acta Radiol Oncol; 1983 Apr 15; 22(1):9-12. PubMed ID: 6305140
    [Abstract] [Full Text] [Related]

  • 33. [Antimetabolites and pregnancy. Normal child born to a mother under treatment 8 years for chronic myeloid leukemia].
    Salmon M, Orsini A, Giraud F, Perrimond H, Gonggryp N.
    Bull Acad Natl Med; 1972 Feb 01; 156(4):123-32. PubMed ID: 4629812
    [No Abstract] [Full Text] [Related]

  • 34. [Observations on the terminal course of chronic myeloid leukemia treated by alkylating agents (busulfan)].
    Giovanelli E.
    Minerva Med; 1970 May 19; 61(37):2038-41. PubMed ID: 4097050
    [No Abstract] [Full Text] [Related]

  • 35. [Chronic myeloid leukaemia. Clinical study and analysis of therapeutical results in 55 cases].
    Lamas S, Sanjuán I, Zabala P, Millán I, Cabrera R, Barbolla L, Menéndez J, Fernández MN.
    Sangre (Barc); 1982 May 19; 27(4A):493-507. PubMed ID: 6961564
    [No Abstract] [Full Text] [Related]

  • 36. [Radiation therapy in chronic myeloleukemia].
    Frinovskaia IV, Markarian VG.
    Sov Med; 1979 Aug 19; (8):27-31. PubMed ID: 293054
    [No Abstract] [Full Text] [Related]

  • 37. [Analysis of clinical and laboratory prognostic indices in chronic myeloid leukemia (author's transl)].
    Kotlarek-Haus S, Becker M, Dorczak K.
    Przegl Lek; 1977 Aug 19; 34(4):407-11. PubMed ID: 267958
    [No Abstract] [Full Text] [Related]

  • 38. [Results of treatment and survival time in chronic granulocytic leukemia].
    Pawlowski J.
    Przegl Lek; 1969 Aug 19; 25(3):305-9. PubMed ID: 4182966
    [No Abstract] [Full Text] [Related]

  • 39. Chronic myeloid leukaemia: course, life expectancy, and an analysis of dibromomannitol and busulfan treatment.
    Gerhartz H.
    Haematologica; 1972 Apr 19; 57(11):775-86. PubMed ID: 4200312
    [No Abstract] [Full Text] [Related]

  • 40. [Results of spleen irradiation in 175 clinical cases of chronic myeloid leukemia].
    Schoen D, Bauer R.
    Strahlentherapie; 1968 Jan 19; 135(1):1-10. PubMed ID: 5243751
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 10.